FDA Approves First-Ever Treatment for Thyroid Eye Disease

The Food and Drug Administration (FDA) announced on Tuesday that it had just approved the first-ever treatment for thyroid eye disease (TED), Tepezza, which is developed by Horizon Therapeutics (NASDAQ: HZNP).